Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers

The use of generic drugs has been increasing. However, studies of the safety of generic cisplatin (CDDP) for the treatment of head and neck cancer (HNC) have not been reported. This study investigated the treatment completion rates and incidence of CDDP-related adverse events in patients with advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimada, Rie, Tsukahara, Kiyoaki, Takase, Soichiro, Okamoto, Isaku, Sato, Hiroki, Katsube, Yasuaki, Maruyama, Ryo, Shimizu, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802811/
https://www.ncbi.nlm.nih.gov/pubmed/29434483
http://dx.doi.org/10.1177/1179670717749231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802811/
https://www.ncbi.nlm.nih.gov/pubmed/29434483
http://dx.doi.org/10.1177/1179670717749231

Ejemplares similares